MBRX icon

Moleculin Biotech

16 hedge funds and large institutions have $1.95M invested in Moleculin Biotech in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, reducing their positions, and 6 closing their positions.

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VKH
1
Virtu KCG Holdings
New York
$676K 361,351 +127,357 +54%
Vanguard Group
2
Vanguard Group
Pennsylvania
$631K 337,321 +73,161 +28%
Truist Financial
3
Truist Financial
North Carolina
$168K 90,000 +50,000 +125%
TSS
4
Two Sigma Securities
New York
$144K 76,945 +52,785 +218%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$110K 58,888 +58,888 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$52K 27,962 +27,962 New
Bank of America
7
Bank of America
North Carolina
$47K 25,000
UBS Group
8
UBS Group
Switzerland
$26K 13,606 +7,069 +108%
Jane Street
9
Jane Street
New York
$22K 11,535 +11,535 New
Northern Trust
10
Northern Trust
Illinois
$21K 11,155
Morgan Stanley
11
Morgan Stanley
New York
$21K 11,263 +467 +4%
WS
12
Wedbush Securities
California
$19K 10,000
OIA
13
OneDigital Investment Advisors
Kansas
$5K 2,800 +2,800 New
AWMS
14
Advocacy Wealth Management Services
Georgia
$2K 1,000
WA
15
WFG Advisors
Texas
$1K 400
NFG
16
Next Financial Group
Texas
$1K 500 +500 New
SM
17
Sabby Management
Florida
-100,000 Closed
BlackRock
18
BlackRock
New York
-17,868 Closed
Goldman Sachs
19
Goldman Sachs
New York
-17,509 Closed
Citadel Advisors
20
Citadel Advisors
Florida
-17,304 Closed
TRCT
21
Tower Research Capital (TRC)
New York
-3,100 Closed
AIM
22
Acrospire Investment Management
Illinois
-2,472 Closed
IA
23
IFP Advisors
Florida